Characteristics of diabetes mellitus patients in Turkey: An analysis of national electronic health records.


Journal

Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 21 07 2022
accepted: 26 12 2022
entrez: 22 3 2023
pubmed: 23 3 2023
medline: 24 3 2023
Statut: ppublish

Résumé

It was estimated that there were 537 million people with diabetes mellitus in 2021, representing 10.5% of the global adult population. Diabetes prevalence in Turkey is 13.5%, according to a meta-analysis and 17.3% according to a recent study. Although the primary purpose of Electronic Health Records (EHRs) is clinical, researchers can use them to conduct epidemiologic investigations. This study aims to document the prevalence of diabetes and to evaluate the healthcare utilization of people with diabetes compared to the people without diabetes, based on national EHR. Only people over 14 years old were included in the analysis. Our criteria for being diabetic were 1) having an HbA1c over 6.5% (48 mmol/mol), 2) having a prescription with DM diagnosis, ICD-10 codes E10-E14, or 3) having at least two fasting blood glucose measurements over 126 mg/dl. At the end of 2020, there were 7,178,674 individuals with diabetes, with 11.12% prevalence, 13.10% in women while 9.12% in men. Age-adjusted healthcare facility admission per capita was 15.5 for people with diabetes, 9.5 for people without diabetes, while the number of prescriptions was 7.9 for people with diabetes while 4.5 for people without diabetes in 2019. The mean number of prescriptions containing antidiabetics was 2.88 per person with diabetes in 2019. Approximately 11% of Turkish people have diagnosed with diabetes. We estimate that about one-third of people with diabetes are undiagnosed and the majority of these people are men. The results show that such large databases have the capability of supplying a vast amount of information to the scientific community.

Sections du résumé

BACKGROUND BACKGROUND
It was estimated that there were 537 million people with diabetes mellitus in 2021, representing 10.5% of the global adult population. Diabetes prevalence in Turkey is 13.5%, according to a meta-analysis and 17.3% according to a recent study. Although the primary purpose of Electronic Health Records (EHRs) is clinical, researchers can use them to conduct epidemiologic investigations. This study aims to document the prevalence of diabetes and to evaluate the healthcare utilization of people with diabetes compared to the people without diabetes, based on national EHR.
METHODS METHODS
Only people over 14 years old were included in the analysis. Our criteria for being diabetic were 1) having an HbA1c over 6.5% (48 mmol/mol), 2) having a prescription with DM diagnosis, ICD-10 codes E10-E14, or 3) having at least two fasting blood glucose measurements over 126 mg/dl.
RESULTS RESULTS
At the end of 2020, there were 7,178,674 individuals with diabetes, with 11.12% prevalence, 13.10% in women while 9.12% in men. Age-adjusted healthcare facility admission per capita was 15.5 for people with diabetes, 9.5 for people without diabetes, while the number of prescriptions was 7.9 for people with diabetes while 4.5 for people without diabetes in 2019. The mean number of prescriptions containing antidiabetics was 2.88 per person with diabetes in 2019.
DISCUSSION CONCLUSIONS
Approximately 11% of Turkish people have diagnosed with diabetes. We estimate that about one-third of people with diabetes are undiagnosed and the majority of these people are men. The results show that such large databases have the capability of supplying a vast amount of information to the scientific community.

Identifiants

pubmed: 36945956
doi: 10.55730/1300-0144.5587
pmc: PMC10387848
doi:

Substances chimiques

Blood Glucose 0
Hypoglycemic Agents 0

Types de publication

Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

316-322

Références

Curr Vasc Pharmacol. 2020;18(2):104-109
pubmed: 30961501
Diabetes Res Clin Pract. 2007 Mar;75(3):313-9
pubmed: 16934906
Yearb Med Inform. 2014 May 22;9:228-34
pubmed: 24853036
Acta Diabetol. 2021 Mar;58(3):267-278
pubmed: 32770407
Turk Kardiyol Dern Ars. 2018 Oct;46(7):546-555
pubmed: 30391984
Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33
pubmed: 33298413
Diabet Med. 2018 Dec;35(12):1727-1734
pubmed: 30153351
J Am Med Inform Assoc. 2013 Dec;20(e2):e319-26
pubmed: 24026307
Annu Rev Public Health. 2016;37:61-81
pubmed: 26667605
Diabetologia. 2017 Sep;60(9):1566-1576
pubmed: 28776081
Diabetes Res Clin Pract. 2022 Jan;183:109119
pubmed: 34879977
Diabetes Care. 2018 May;41(5):917-928
pubmed: 29567642
Nat Rev Endocrinol. 2016 Oct;12(10):616-22
pubmed: 27388988
Diabet Med. 2012 Jun;29(6):784-91
pubmed: 22050477
Adv Ther. 2019 Jan;36(1):44-58
pubmed: 30465123
Chin Med J (Engl). 2020 May 20;133(10):1224-1230
pubmed: 32433055
J Am Med Inform Assoc. 2017 Apr 01;24(e1):e121-e128
pubmed: 27616701

Auteurs

Mustafa Mahir Ülgü (MM)

Ministry of Health, Ankara, Turkey; Department of Biostatistics and Medical Informatics, Faculty of Medicine, Akdeniz University, Antalya, Turkey.

Kemal Hakan Gülkesen (KH)

Department of Biostatistics and Medical Informatics, Faculty of Medicine, Akdeniz University, Antalya, Turkey.

Abdullah Akünal (A)

Ministry of Health, Ankara, Turkey.

Mustafa Okan Ayvalı (MO)

Ministry of Health, Ankara, Turkey.

Neşe Zayim (N)

Department of Biostatistics and Medical Informatics, Faculty of Medicine, Akdeniz University, Antalya, Turkey.

Şuayip Birinci (Ş)

Department of Biostatistics and Medical Informatics, Faculty of Medicine, Akdeniz University, Antalya, Turkey.

Mustafa Kemal Balcı (MK)

Division of Endocrinology, Faculty of Medicine, Akdeniz University, Antalya, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH